Language:
English
繁體中文
Help
Login
Back
Switch To:
Labeled
|
MARC Mode
|
ISBD
Antibody therapy = substitution - im...
~
SpringerLink (Online service)
Antibody therapy = substitution - immunomodulation - monoclonal immunotherapy /
Record Type:
Language materials, printed : Monograph/item
Title/Author:
Antibody therapy/ edited by Paul Imbach.
Reminder of title:
substitution - immunomodulation - monoclonal immunotherapy /
other author:
Imbach, Paul.
Published:
Cham :Springer International Publishing : : 2018.,
Description:
xiv, 363 p. :ill., digital ; : 24 cm.;
Contained By:
Springer eBooks
Subject:
Immunoglobulins - Therapeutic use. -
Online resource:
http://dx.doi.org/10.1007/978-3-319-68038-5
ISBN:
9783319680385
Antibody therapy = substitution - immunomodulation - monoclonal immunotherapy /
Antibody therapy
substitution - immunomodulation - monoclonal immunotherapy /[electronic resource] :edited by Paul Imbach. - Cham :Springer International Publishing :2018. - xiv, 363 p. :ill., digital ;24 cm.
This practical manual, written by well-known experts, reviews current indications for the use of IgG concentrates and some other modern immunomodulators and provides fundamental information on present-day immunomodulation in patients (and mice) The book opens by tracing the transition from IgG substitution to IgG immunomodulation and providing expert updates on immunomodulatory indications in autoimmune and inflammatory disorders, including hematologic, neurologic, dermatologic, and other diseases. Basic aspects of IgG concentrates, including methods of production, safety, currently available products, and mechanisms of action, are then discussed. An entire chapter is devoted to the different aspects of immunomodulatory IgG treatment in the bleeding disorder immune thrombocytopenia (ITP) Finally, the transition from polyclonal to monoclonal antibody (mAb) treatment is addressed in detail, covering mAb development, methods, mechanisms of action, adverse effects, and more. Particular attention is paid to the example of anti-CD20 (B-cell) antibody.
ISBN: 9783319680385
Standard No.: 10.1007/978-3-319-68038-5doiSubjects--Topical Terms:
676924
Immunoglobulins
--Therapeutic use.
LC Class. No.: QR186.7 / .A585 2018
Dewey Class. No.: 616.0792
Antibody therapy = substitution - immunomodulation - monoclonal immunotherapy /
LDR
:02003nam a2200301 a 4500
001
925263
003
DE-He213
005
20181015141251.0
006
m d
007
cr nn 008maaau
008
190625s2018 gw s 0 eng d
020
$a
9783319680385
$q
(electronic bk.)
020
$a
9783319680378
$q
(paper)
024
7
$a
10.1007/978-3-319-68038-5
$2
doi
035
$a
978-3-319-68038-5
040
$a
GP
$c
GP
041
0
$a
eng
050
4
$a
QR186.7
$b
.A585 2018
072
7
$a
MJF
$2
bicssc
072
7
$a
MED038000
$2
bisacsh
082
0 4
$a
616.0792
$2
23
090
$a
QR186.7
$b
.A629 2018
245
0 0
$a
Antibody therapy
$h
[electronic resource] :
$b
substitution - immunomodulation - monoclonal immunotherapy /
$c
edited by Paul Imbach.
260
$a
Cham :
$c
2018.
$b
Springer International Publishing :
$b
Imprint: Springer,
300
$a
xiv, 363 p. :
$b
ill., digital ;
$c
24 cm.
520
$a
This practical manual, written by well-known experts, reviews current indications for the use of IgG concentrates and some other modern immunomodulators and provides fundamental information on present-day immunomodulation in patients (and mice) The book opens by tracing the transition from IgG substitution to IgG immunomodulation and providing expert updates on immunomodulatory indications in autoimmune and inflammatory disorders, including hematologic, neurologic, dermatologic, and other diseases. Basic aspects of IgG concentrates, including methods of production, safety, currently available products, and mechanisms of action, are then discussed. An entire chapter is devoted to the different aspects of immunomodulatory IgG treatment in the bleeding disorder immune thrombocytopenia (ITP) Finally, the transition from polyclonal to monoclonal antibody (mAb) treatment is addressed in detail, covering mAb development, methods, mechanisms of action, adverse effects, and more. Particular attention is paid to the example of anti-CD20 (B-cell) antibody.
650
0
$a
Immunoglobulins
$x
Therapeutic use.
$3
676924
650
1 4
$a
Medicine & Public Health.
$3
593949
650
2 4
$a
Hematology.
$3
645254
650
2 4
$a
Immunology.
$3
592892
650
2 4
$a
Oncology.
$3
593951
700
1
$a
Imbach, Paul.
$3
786776
710
2
$a
SpringerLink (Online service)
$3
593884
773
0
$t
Springer eBooks
856
4 0
$u
http://dx.doi.org/10.1007/978-3-319-68038-5
950
$a
Medicine (Springer-11650)
based on 0 review(s)
Multimedia
Reviews
Add a review
and share your thoughts with other readers
Export
pickup library
Processing
...
Change password
Login